Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2017
Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2017 Compliance Certificate For The Period Ended 31St March, 2017
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Half year ended 31st March, 2017 Statement Of Investor Complaints For The Quarter Ended 31.03.2017 Under Regulation 13(3) Of SEBI (LODR), Regulations, 2015
Pursuant to regulation 13(3) of SEBI (LODR), Regulations, 2015 please find below the Statement of Investor Complaints for the Quarter ended 31st March, 2017: 01No. of complaints pending at the beginning of the quarterNil 02No. of complaints received during the quarter Nil 03No. of complaints resolved during then quarter Nil 04No. of complaints unresolved during then quarter Nil This is for your... Shareholding for the Period Ended March 31, 2017
Lotus Eye Care Hospital Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Outcome of Board Meeting
Lotus Eye Care Hospital Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 31, 2017, inter alia, has noted and approved the following:1. Resignation of Mr. M.Venkatachalapathi as Chief Financial Officer (CFO) of the Company w.e.f. January 17, 2017.2. Appointment of Mr. S.Saravana Ganesh as Chief Financial Officer (CFO) and Key Managerial Personnel of the Company w.e.f. January 31, 2017.... Standalone Financial Results, Limited Review Report for December 31, 2016
Lotus Eye Care Hospital Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vramath Investment Consultancy Pvt Ltd Resignation of Chief Financial Officer
Lotus Eye Care Hospital Ltd has informed BSE that Mr. M. Venkatachalapathi, Chief Financial Officer and Key Managerial Personnel of the Company tendered his resignation as a Chief Financial Officer of the Company due to personal reasons, effective from the closure of the business hours of January 17, 2017. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Lotus Eye Care Hospital Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Board Meeting Intimation for Results & Closure of Trading Window
Lotus Eye Care Hospital Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on January 31, 2017, inter alia, to consider and approve the Un-audited Financial Results for the Quarter/Nine Months ended December 31, 2016.Further, the trading window, in terms of code of conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, shall remain closed for all the Designated Person(s) (including...